Conformation of the nootropic agents 1-(4-methoxybenzoyl)-5-oxo-2-pyrrolidinepropanoic acid (CI-933) and 4-hydroxymethyl-1-benzyl-pyrrolidin-2-one (WEB-1868): X-ray crystal structures, theoretical MO calculations (AM-1) and 600 MHZ 1H NMR spectra
- 1 May 1990
- journal article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 222 (3-4) , 487-502
- https://doi.org/10.1016/0022-2860(90)85055-n
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- X-ray crystal structure, dipole moment and theoretical molecular orbital study of the cognition activator dihydro-1H-pyrrolizine-3,5(2H, 6H)-dione (‘rolziracetam’)European Journal of Medicinal Chemistry, 1989
- Solid-state structure and conformation of the cognition activator 3-phenoxypyridine sulphate: X-ray, two-dimensional 1H NMR and 13C NMR, and theoretical Mo-MNDO studiesJournal of Molecular Structure, 1988
- Molecular determinants for drug-receptorsJournal of Molecular Structure, 1987
- Solid-state structure and solution conformation of the nootropic agent N[2-(N,N-Diisopropylamino)ethyl]-2-oxo-1-pyrrolidinacetamide sulphate. X-ray and homonuclear two-dimensional 1H NMR studiesJournal of Molecular Structure, 1987
- Drug development for senile cognitive declineJournal of Medicinal Chemistry, 1986
- The Effects of Piracetam in Children with DyslexiaJournal of Clinical Psychopharmacology, 1985
- Piracetam in Alcoholic Psychoses: A Double-Blind, Crossover, Placebo Controlled StudyJournal of International Medical Research, 1985
- Solid-state structure and conformation of the nootropic agent 4-hydroxy-2-oxo-1-pyrrolidineacetamide: X-ray and theoretical self-consistant field molecular orbital (SCF-MO) studies.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- CI-933Drugs of the Future, 1985
- Nootropic drugs: Animal models for studying effects on cognitionDrug Development Research, 1984